Allergy Therapeutics plc

(PINK:AGYTF)

Latest On Allergy Therapeutics plc (AGYTF):

Date/Time Type Description Signal Details
2021-09-23 21:24 ESTNewsAllergy Therapeutics reports FY resultsN/A
2021-03-05 10:21 ESTFinancialsCompany financials have been released.Neutral
2020-12-04 06:37 ESTFinancialsCompany financials have been released.Neutral
2020-11-27 01:04 ESTFinancialsCompany financials have been released.Neutral
2020-10-08 21:26 ESTFinancialsCompany financials have been released.Neutral
2020-10-04 15:42 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 16:49 ESTFinancialsCompany financials have been released.Neutral
2020-09-25 07:38 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 09:28 ESTFinancialsCompany financials have been released.Neutral
2020-08-31 08:41 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 12:54 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 16:37 ESTFinancialsCompany financials have been released.Neutral
2020-08-04 19:55 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 12:17 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 04:47 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 20:55 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 08:42 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 01:01 ESTFinancialsCompany financials have been released.Neutral
2020-07-28 15:57 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 16:35 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 21:26 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 12:45 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 07:45 ESTFinancialsCompany financials have been released.Neutral
2020-07-03 07:23 ESTFinancialsCompany financials have been released.Neutral
2020-07-02 23:49 ESTFinancialsCompany financials have been released.Neutral
2020-07-02 07:23 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 20:25 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 04:16 ESTFinancialsCompany financials have been released.Neutral

About Allergy Therapeutics plc (AGYTF):

Allergy Therapeutics plc engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies, particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex, Pollinex Quattro, Oralvac, Acarovac Plus, Acarovac MPL, Venomil, Synbiotics, Penicillin Diagnostics, and Peanut. The company also develops allergy vaccines for grass, tree, and house dust mite, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.

See Advanced Chart

General

  • Name Allergy Therapeutics plc
  • Symbol AGYTF
  • Type Common Stock
  • Exchange PINK
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 600
  • Fiscal Year EndJune
  • Web URLhttp://www.allergytherapeutics.com
View More

Valuation

  • Trailing PE 0.01
  • Price/Sales (Trailing 12 Mt.) 1.51
  • Price/Book (Most Recent Quarter) 2.57
  • Enterprise Value Revenue 1.76
  • Enterprise Value EBITDA 11.01
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Profit Margin 8%
  • Return on Assets 5%
  • Return on Equity 12%
  • Revenue Per Share $0
  • Gross Profit 58 million
  • Quarterly Earnings Growth 7.1%
View More

Highlights

  • Market Capitalization 202.64 million
View More

Share Statistics

  • Shares Outstanding 640.79 million
  • Shares Float 359.34 million
  • % Held by Insiders 8635%
  • % Held by Institutions 11.54%
View More

Technicals

  • Beta 1.63
  • 52 Week High $0.35
  • 50 Day Moving Average 0.26
  • 200 Day Moving Average 0.18
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Allergy Therapeutics plc (AGYTF) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Allergy Therapeutics plc (AGYTF) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-12-31$N/A$0.02$0.00
2020-06-302020-09-30$N/A$0.01$0.00
2020-03-312020-06-30$N/A-$0.01$0.00
2019-12-312020-03-31$25.24 million-$0.01$0.00
2019-09-302019-12-31$25.24 million$0.02$0.00
2019-06-302019-09-30$13.5 million$0.01$0.00
2019-03-312019-06-30$13.5 million-$0.01$0.00
2018-12-312019-03-31$23.36 million-$0.01$0.00
2018-09-302018-12-31$23.36 million$0.01$0.00
2018-06-302018-09-30$13.05 million$0.01$0.00
2018-03-312018-06-30$13.05 million-$0.02$0.00
2017-12-312018-03-31$21.12 million-$0.02$0.00
2017-09-302017-12-31$21.12 million$0.01$0.00
2017-06-302017-09-30$11.86 million$0.01$0.00
2017-03-312017-06-30$11.86 million-$0.01$0.00
2016-12-312017-03-31-$0.01$0.00
2016-09-302016-12-31$0.01$0.00
2016-06-302016-09-30$0.01$0.00
2016-03-312016-06-30-$0.02$0.00
2015-12-312016-03-31-$0.02$0.00
2015-09-302015-12-31$0.00$0.00
2015-06-302015-09-30$0.00$0.00
2015-03-312015-06-30-$0.01$0.00
2014-12-312015-03-31-$0.01$0.00
2014-09-302014-12-31$0.01$0.00
2014-06-302014-09-30$0.01$0.00
2014-03-312014-06-30-$0.01$0.00
2013-12-312014-03-31-$0.01$0.00
2013-09-302013-12-31$0.01$0.00
2013-06-302013-09-30$0.01$0.00
2013-03-312013-06-30-$0.01$0.00
2012-12-312013-03-31-$0.01$0.00
2012-09-302012-12-31$0.01$0.00
2012-06-302012-09-30$0.01$0.00
2012-03-312012-06-30-$0.02$0.00
2011-12-312012-03-31-$0.02$0.00
2011-09-302011-12-31$0.02$0.00
2011-06-302011-09-30$0.02$0.00
2011-03-312011-06-30-$0.02$0.00
2010-12-312011-03-31-$0.02$0.00
2010-09-302010-12-31$0.01$0.00

Allergy Therapeutics plc (AGYTF) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Allergy Therapeutics plc (AGYTF) Chart:

Allergy Therapeutics plc (AGYTF) News:

Below you will find a list of latest news for Allergy Therapeutics plc (AGYTF) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Allergy Therapeutics plc (AGYTF) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Allergy Therapeutics plc (AGYTF) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link